Molecular techniques used in non-invasive pre-implantation genetic testing: current approaches, applications and challenges

Sana Sharin Odayapurath; Fathima Noorah Thazhathu Kadavu; Khadeejathul Safwana Pallath; Gauri Krishna Govindam; Barry C. Hynniewta

doi:10.18203/2320-1770.ijrcog20263482

Authors

Sana Sharin Odayapurath Department of Clinical Embryology, Yenepoya School of Allied Health Sciences, Yenepoya (deemed to-be) University, Mangalore, Karnataka, India
Fathima Noorah Thazhathu Kadavu Department of Clinical Embryology, Yenepoya School of Allied Health Sciences, Yenepoya (deemed to-be) University, Mangalore, Karnataka, India
Khadeejathul Safwana Pallath Department of Clinical Embryology, Yenepoya School of Allied Health Sciences, Yenepoya (deemed to-be) University, Mangalore, Karnataka, India
Gauri Krishna Govindam Department of Clinical Embryology, Yenepoya School of Allied Health Sciences, Yenepoya (deemed to-be) University, Mangalore, Karnataka, India
Barry C. Hynniewta Department of Clinical Embryology, MOMSOON Fertility and IVF Centre, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20263482

Keywords:

Preimplantation genetic testing, Non-invasive preimplantation genetic testing, Next-generation sequencing, Whole-genome amplification, Cell-free DNA

Abstract

Preimplantation genetic testing (PGT) represents an important diagnostic method in assisted reproductive technology (ART) for the screening of chromosomal and genetic aberrations prior to embryo transfer. Non-invasive PGT (niPGT) is a new technology that analyzes cell-free embryonic DNA (cfDNA) released into spent culture media. This is a safer method than conventional PGT that uses invasive biopsies of embryos that can damage their viability. Advanced molecular techniques support the diagnostic accuracy of NiPGT: array comparative genomic hybridization (aCGH) allows genome-wide detection of whole-chromosome aneuploidies and copy number variations through comparative hybridization. Next-generation sequencing (NGS) allows high-throughput deep-coverage analysis with extended dynamic range and allows detection of whole-chromosome aneuploidies, segmental defects and intermediate mosaic thresholds on all 24 chromosomes. Because embryonic cfDNA is so fragmented and present only in trace picogram quantities, whole genome amplification (WGA) is needed to amplify the genetic material for downstream analysis, and other targeted approaches such as quantitative PCR (qPCR) and high-density single nucleotide polymorphism (SNP) arrays are also important, as they enable copy count calculation and provide vital haplotype-specific information on parental inheritance patterns. niPGT has high embryo concordance rates, ranging from 76% to 91%, when compared to conventional biopsies, but it presents significant technical challenges, including maternal DNA contamination from cumulus cells or maternal shedding, which can mask true embryonic aneuploidies and lead to false-negative results, as well as unequal amplification biases and artifacts generated during WGA. Continued refinement of sequencing and amplification protocols, together with more robust clinical validation, will be needed before niPGT can be widely adopted in routine practice.

References

Giuliano R, Maione A, Vallefuoco A, Sorrentino U, Zuccarello D. Preimplantation genetic testing for genetic diseases: limits and review of current literature. Genes. 2023;14(11):2095.

Poli M, Picchetta L, Siciliani L, Capalbo A. Evidence-Based Reporting in Preimplantation Genetic Testing (PGT). Genes. 2025;16(9):1083.

Doroftei B, Ilie OD, Anton N, Armeanu T, Ilea C. A mini-review regarding the clinical outcomes of in vitro fertilization (IVF) following pre-implantation genetic testing (PGT)-next generation sequencing (NGS) approach. Diagnostics. 2022;12(8):1911.

Nguyen HT, Luu TT, Đo LT, Nguyen TC, Nguyen DT, Ho TT, et al. Non-invasive preimplantation genetic testing for aneuploidy using cell-free DNA in blastocyst culture medium. J Assist Reprod Genet. 2025;42(8):2587-95.

Yang S, Li R, Xu B, Wu Y, Li J, Fu X. Clinical application progress and prospects of non-invasive preimplantation genetic testing (niPGT): A review. Clin Chim Acta. 2026;587:120945.

Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74(12):5463-7.

Smith LM, Sanders JZ, Kaiser RJ, Hughes P, Dodd C, Connell CR, et al. Fluorescence detection in automated DNA sequence analysis. Nature. 1986;321(6071):674-9.

Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008;26(10):1135-45.

Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet. 2010;11(1):31-46.

Krzyminiewski R, Dobosz B, Krist B, Schroeder G, Kurczewska J, Bluyssen HA. ESR method in monitoring of nanoparticle endocytosis in cancer cells. Int J Mol Sci. 2020;21(12):4388.

García-Pascual CM, Navarro-Sánchez L, Navarro R, Martínez L, Jiménez J, Rodrigo L, et al. Optimized NGS approach for detection of aneuploidies and mosaicism in PGT-A and imbalances in PGT-SR. Genes. 2020;11(7):724.

Palmerola KL, Vitez SF, Amrane S, Fischer CP, Forman EJ. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A). J Assist Reprod Genet. 2019;36(1):153-7.

Tomic M, Vrtacnik Bokal E, Stimpfel M. Non-invasive preimplantation genetic testing for aneuploidy and the mystery of genetic material: a review article. Int J Mol Sci. 2022;23(7):3568.

Huang L, Bogale B, Tang Y, Lu S, Xie XS, Racowsky C. Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsy. Proc Natl Acad Sci U S A. 2019;116(28):14105-12.

Lledo B, Morales R, Ortiz JA, Rodriguez-Arnedo A, Ten J, Castillo JC, et al. Consistent results of non-invasive PGT-A of human embryos using two different techniques for chromosomal analysis. Reprod Biomed Online. 2021;42(3):555-63.

Mrugacz G, Mospinek A, Głowacka J, Sprawski O, Kawałek L, Gąsior W, et al. Noninvasive Preimplantation Genetic Testing in Recurrent Pregnancy Loss and Implantation Failure: Breakthrough or Overpromise? Cells. 2025;14(20):1591.

Voros C, Darlas M, Athanasiou D, Athanasiou A, Athanasiou A, Bananis K, et al. Evaluation of the effectiveness and accuracy of non-invasive preimplantation genetic testing (niPGT) compared to invasive embryo biopsy. Biomedicines. 2025;13(8):2010.

Bakalova DN, Navarro-Sánchez L, Rubio C. Non-invasive preimplantation genetic testing. Genes. 2025;16(5):552.

Sun BL, Wang Y, Zhou L, Zhang CH, Wu ZX, Qiao J, et al. Effectiveness of non-invasive chromosomal screening for normal karyotype and chromosomal rearrangements. Front Genet. 2023;14:1036467.

Kakourou G, Mamas T, Vrettou C, Traeger-Synodinos J. An update on non-invasive approaches for genetic testing of the preimplantation embryo. Curr Genom. 2022;23(5):337-52.

Viotti M. Preimplantation genetic testing for chromosomal abnormalities: aneuploidy, mosaicism, and structural rearrangements. Genes. 2020;11(6):602.

Zhang Z, Qiao J, Chen Y, Zhou P. Genetic Deconvolution of Embryonic and Maternal Cell‐Free DNA in Spent Culture Medium of Human Preimplantation Embryo Through Deep Learning. Adv Sci. 2025;12(34):e12660.

Jäger R. Special issue on whole genome amplification. Int J Mol Sci. 2023;24(11):9626.

Khan T, Becker TM, Po JW, Chua W, Ma Y. Single-circulating tumor cell whole genome amplification to unravel cancer heterogeneity and actionable biomarkers. Int J Mol Sci. 2022;23(15):8386.

⁠Ordóñez CD, Redrejo-Rodríguez M. DNA polymerases for whole genome amplification: considerations and future directions. Int J Mol Sci. 2023;24(11):9331.

Volozonoka L, Miskova A, Gailite L. Whole genome amplification in preimplantation genetic testing in the era of massively parallel sequencing. Int J Mol Sci. 2022;23(9):4819.

Hanson B, Paternoster B, Povarnitsyn N, Scotchman E, Chitty L, Chandler N. Non-invasive prenatal diagnosis (NIPD): current and emerging technologies. Extracell Vesicles Circ Nucl Acids. 2023;4(1):3-26.

Greco E, Litwicka K, Minasi MG, Cursio E, Greco PF, Barillari P. Preimplantation genetic testing: where we are today. Int J Mol Sci. 2020;21(12):4381.

Brezina PR, Anchan R, Kearns WG. Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences? J Assist Reprod Genet. 2016;33(7):823-32.

Fernandes SL, de Carvalho FA. Preimplantation genetic testing: A narrative review. RISE Health Res J. 2024;9(4):262.

Karami N, Iravani F, Bavarsad SB, Asadollahi S, Hoseini SM, Montazeri F, et al. Comparing the advantages, disadvantages and diagnostic power of different non-invasive pre-implantation genetic testing: A literature review. Int J Reprod BioMed. 2024;22(3):177.

ESHRE PGT. Consortium Steering Committee, Carvalho F, Coonen E, Goossens V, Kokkali G, Rubio C, et al. ESHRE PGT consortium good practice recommendations for the organisation of PGT. Hum Reprod Open. 2020;2020(3):hoaa021.

Cimadomo D, Rienzi L, Capalbo A, Rubio C, Innocenti F, García-Pascual CM, et al. The dawn of the future: 30 years from the first biopsy of a human embryo. The detailed history of an ongoing revolution. Hum Reprod Update. 2020;26(4):453-73.

Cornelisse S, Zagers M, Kostova E, Fleischer K, van Wely M, Mastenbroek S. Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation. Cochrane Database Syst Rev. 2020;9(9):CD005291.

Parikh FR, Athalye AS, Naik NJ, Naik DJ, Sanap RR, Madon PF. Preimplantation genetic testing: its evolution, where are we today? J Hum Reprod Sci. 2018;11(4):306-14.

Gudapati S, Chaudhari K, Shrivastava D, Yelne S. Advancements and applications of preimplantation genetic testing in in vitro fertilization: a comprehensive review. Cureus. 2024;16(3):e57357.